54 results
6-K
EX-99.2
AMYT
Amryt Pharma Plc
11 May 22
Current report (foreign)
4:30pm
receivable. During the six months ended June, 2021, one customer comprised greater than 90% of our accounts receivable and product revenues.
We … such costs will be amortized.
Revenue Recognition
In accordance with accounting guidance for revenue recognition, we recognize revenue when a customer
425
AMYT
Amryt Pharma Plc
5 May 21
Business combination disclosure
5:25pm
, in the U.S, with potential for approval in other jurisdictions.
By combining the businesses we will be able to increase the scale of our U.S customer
6-K
EX-99.1
xswqve wfmn
6 Aug 20
Amryt Announces Q2 2020 Results and Issues Positive Revenue Guidance for Fy 2020
9:43am
6-K
EX-99.5
xv9j4t e664uhho
4 Aug 22
Results of Annual General Meeting
7:38am
6-K
EX-99.1
ip4kkhmz35d
5 Nov 20
Amryt Reports Record Q3 2020 Results - Raising FY 2020 Revenue Guidance
7:55am
6-K
EX-99.1
6yp 8pa8e
4 May 22
Amryt Reports Record Q1 2022 Results
7:43am
424B3
j6cmdo 6wr
4 May 22
Prospectus supplement
8:35am
424B3
37psrpkk7nkw blbx6i
9 Mar 22
Prospectus supplement
9:26am
6-K
EX-99.7
bpn ksvo3
3 Nov 22
Current report (foreign)
7:44am
424B3
103jy0t5m8 kj4
9 Mar 22
Prospectus supplement
9:25am
424B3
g0aca0fyo
4 May 22
Prospectus supplement
7:45am
6-K
EX-99.1
uag9qvjzn9o3bws
9 Mar 22
Amryt Announces 22% growth in FY 2021 Revenues to $222.5M
9:23am
6-K
EX-99.5
pqw6fw
5 May 21
Agreement and Plan of Merger
5:19pm
425
ptczcu4
5 May 21
Business combination disclosure
5:24pm
6-K
EX-99.1
ohi0 uhhy
5 May 21
Amryt Pharma to Acquire Chiasma, Inc. to Further Strengthen Global Leadership in Rare and Orphan Diseases
8:45am
6-K
EX-99.1
bhssif 9kvyx7n1
5 May 21
Amryt Reports Record Q1 2021 Financial and Operating Results
9:40am